CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase 1B, Open-Label, Dose Escalation and Cohort Expansions Trial of Naptumomab Estafenatox (NAP, ABR-217620) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced or Metastatic Solid Tumors
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03983954
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:28:54.931221+00:00
- Published At
- 2025-11-28T00:00:00+00:00
- Record Updated At
- 2025-11-28
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["ER+ Breast Cancer", "Ovarian Cancer", "Cervical Squamous Cell Carcinoma", "Pancreatic Adenocarcinoma", "Endometrial Cancer", "Renal Cell Carcinoma", "Urothelial Cancer", "Head and Neck Squamous Cell Carcinoma", "Mesothelioma", "Melanoma", "Hepatocellular Carcinoma", "Prostate Cancer", "NSCLC", "HER2-negative Breast Cancer", "Triple Negative Breast Cancer", "Bladder Cancer", "Colorectal Cancer Metastatic", "GastroEsophageal Cancer", "NSCL2 Gene Mutation", "Esophageal Cancer"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-11-28"- protocolSection.identificationModule.nctId
"NCT03983954"- protocolSection.identificationModule.officialTitle
"Phase 1B, Open-Label, Dose Escalation and Cohort Expansions Trial of Naptumomab Estafenatox (NAP, ABR-217620) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced or Metastatic Solid Tumors"- protocolSection.statusModule.overallStatus
"ACTIVE_NOT_RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.